Effect of menopause on cardiovascular disease and its risk factors: a 9-year follow-up study

References

• Celermajer DS, Chow CK, Marijon E, Anstey NM, Woo KS. Cardiovascular disease in the developing world: prevalences, patterns, and the potential of early disease detection. J Am Coll Cardiol 2012;60:1207–16
   PubMed Web of Science ®Google Scholar
• Agrinier N, Cournot M, Dallongeville J, et al. Menopause and modifiable coronary heart disease risk factors: a population based study. Maturitas 2010;65:237–43
   PubMed Web of Science ®Google Scholar
• Ebrahimpour P, Fakhrzadeh H, Heshmat R, Ghodsi M, Bandarian F, Larijani B. Metabolic syndrome and menopause: a population-based study. Diabetes Metab Syndrome: Clin Res Rev 2010;4:5–9
   Google Scholar
• Torng PL, Su TC, Sung FC, et al. Effects of menopause on intraindividual changes in serum lipids, blood pressure, and body weight – the Chin-Shan community cardiovascular cohort study. Atherosclerosis 2002;161:409–15
   PubMed Web of Science ®Google Scholar
• Wen Y, Doyle MC, Cooke T, Feely J. Effect of menopause on low-density lipoprotein oxidation: is oestrogen an important determinant?Maturitas 2000;34:233–8
   PubMed Web of Science ®Google Scholar
• Antonicelli R, Olivieri F, Morichi V, Urbani E, Mais V. Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy. Int J Cardiol 2008;130:140–6
   PubMed Web of Science ®Google Scholar
• Palmieri D, Perego P, Palombo D. Estrogen receptor activation protects against TNF-α-induced endothelial dysfunction. Angiology 2013 Feb 20. Epub ahead of print
   PubMed Web of Science ®Google Scholar
• He L, Tang X, Li N, et al. Menopause with cardiovascular disease and its risk factors among rural Chinese women in Beijing: a population-based study. Maturitas 2012;72:132–8
   PubMed Web of Science ®Google Scholar
• Casiglia E, Tikhonoff V, Caffi S, et al. Menopause does not affect blood pressure and risk profile, and menopausal women do not become similar to men. J Hypertens 2008;26:1983–92
   PubMed Web of Science ®Google Scholar
• Lukaszewicz R, Lukaszewicz M, Ceremuzyński L. Risk factors of atherosclerosis in premenopausal women with a sense of well-being. A pilot study. Kardiol Pol 2006;64:573–80
   PubMedGoogle Scholar
• Ignarro LJ, Balestrieri ML, Napoli C. Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc Res 2007; 15:326–40
   Google Scholar
• Kanjilal S, Gregg EW, Cheng YJ, et al. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971–2002. Arch Intern Med 2006; 27:2348–55
   Google Scholar
• Azizi F, Ghanbarian A, Momenan AA, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009;10:5
   PubMed Web of Science ®Google Scholar
• Azizi F, Rahmani M, Ghanbarian A, et al. Serum lipid levels in an Iranian adults population: Tehran Lipid and Glucose Study. Eur J Epidemiol.2003;18:311–19
   PubMed Web of Science ®Google Scholar
• Hosseinpanah F, Rambod M, Reza Ghaffari HR, Azizi F. Predicting isolated postchallenge hyperglycaemia: a new approach; Tehran Lipid and Glucose Study (TLGS). Diabet Med 2006;23:982–9
   PubMed Web of Science ®Google Scholar
• Ainsworth BE, Jacobs DR Jr, Leon AS. Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire. Med Sci Sports Exerc 1993;25:92–8
   PubMed Web of Science ®Google Scholar
• Khalili D, Mosavi-Jarrahi A, Eskandari F, et al. Evaluation of cause of deaths’ validity using outcome measures from a prospective, population based cohort study in Tehran, Iran. PLoS One 2012;7:e31427
   Web of Science ®Google Scholar
• Standards of Medical Care in Diabetes 2011. Diabetes Care 2011;34:S11–61
   PubMed Web of Science ®Google Scholar
• Carretero OA, Oparil S. Essential hypertension. I. Definition and etiology. Circulation 2000;101:329–35
   PubMed Web of Science ®Google Scholar
• ATP III guidelines at-a-glance quick desk reference. US Department of Health and Human Services, National Institutes of Health, National Heart Lung and Blood Institute, NIH Publication No. 01-3305, 2001
   Google Scholar
• Johannes J, Bairey Merz CN. Is cardiovascular disease in women inevitable? Preparing for menopause and beyond. Cardiol Rev 2011;19:76
   PubMed Web of Science ®Google Scholar
• Malinauskiene V, Tamosiunas A. Menopause and myocardial infarction risk among employed women in relation to work and family psychosocial factors in Lithuania. Maturitas 2010; 66:94–8
   PubMed Web of Science ®Google Scholar
• Messa C, Notarnicola M, Russo F. Estrogenic regulation of cholesterol biosynthesis and cell growth in DLD-1 human colon cancer cells. Scand J Gastroenterol 2005;40:1454–61
   PubMed Web of Science ®Google Scholar
• Mack WJ, Slater CC, Xiang M, Shoupe D, Lobo RA, Hodis HN. Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause. Fertil Steril 2004;82:391–7
   PubMed Web of Science ®Google Scholar
• Barter P, Gotto AM, LaRosa JC, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007;357:1301–10
   PubMed Web of Science ®Google Scholar
• Lemieux I, Lamarche B, Couillard C, et al. Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med 2001;161:2685–92
   PubMed Web of Science ®Google Scholar
• Sharrett AR, Ballantyne CM, Coady SA, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins AI and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2001;104:1108–13
   PubMed Web of Science ®Google Scholar
• Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ 1991; 303:276–82
   PubMed Web of Science ®Google Scholar
• Peters HW, Westendorp IC, Hak AE, et al. Menopausal status and risk factors for cardiovascular disease. J Intern Med 1999; 246:521–8
   PubMed Web of Science ®Google Scholar
• Poehlman ET, Toth MJ, Ades PA, Rosen CJ. Menopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: a longitudinal study. Eur J Clin Invest 2003;27:322–6
   Google Scholar
• Lovejoy JC. The menopause and obesity. Primary Care-Clinics in Office Practice 2003;30:317–26
   PubMed Web of Science ®Google Scholar
• Davis SR, Castelo-Branco C, Chedraui P, et al. Understanding weight gain at menopause. Climacteric 2012;15:419–29
   PubMed Web of Science ®Google Scholar
• Panotopoulos G, Raison J, Ruiz C, Guy-Grand B, Basdevant A. Weight gain at the time of menopause. Hum Reprod 1997;12: 126–33
   PubMedGoogle Scholar
• Sternfeld B, Wang H, Quesenberry CP Jr, et al. Physical activity and changes in weight and waist circumference in midlife women: findings from the Study of Women's Health Across the Nation. Am J Epidemiol 2004;160:912–22
   PubMed Web of Science ®Google Scholar
• Bailey-Downs LC, Tucsek Z, Toth P, et al. Aging exacerbates obesity-induced oxidative stress and inflammation in perivascular adipose tissue in mice: a paracrine mechanism contributing to vascular redox dysregulation and inflammation. J Gerontol A Biol Sci Med Sci 2013;68:780–92
   PubMed Web of Science ®Google Scholar
• Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg 2008;207:928–34
   PubMed Web of Science ®Google Scholar
• Feng RN, Zhao C, Wang C, et al. BMI is strongly associated with hypertension, and waist circumference is strongly associated with type 2 diabetes and dyslipidemia, in Northern Chinese adults. J Epidemiol 2012;22:317–23
   PubMed Web of Science ®Google Scholar
• Cercato C, Mancini MC, Arguello AM, Passos VQ, Villares SM, Halpern A. Systemic hypertension, diabetes mellitus, and dyslipidemia in relation to body mass index: evaluation of a Brazilian population. Rev Hosp Clin Fac Med Sao Paulo 2004; 59:113–18
   PubMedGoogle Scholar
• Osuji CU, Omejua EG, Onwubuya EI, Ahaneku GI. Serum lipid profile of newly diagnosed hypertensive patients in Nnewi, South-East Nigeria. Int J Hypertens 2012;2012: 710486
   PubMedGoogle Scholar
• Brown CD, Higgins M, Donato KA, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2012;8:605–19
   Google Scholar
• Iughetti L, Predieri B, Bruzzi P, Balli F. Approaches to dyslipidemia treatment in children and adolescents. Expert Rev Endocrinol Metab 2008;3:615–33
   PubMedGoogle Scholar
• Kuh D, Langenberg C, Hardy R, et al. Cardiovascular risk at age 53 years in relation to the menopause transition and use of hormone replacement therapy: a prospective British birth cohort study. BJOG 2005;112:476–85
   PubMed Web of Science ®Google Scholar
• NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms March 21 − 23, 2005. Access date: 5 Feb, 2011. http://consensus.nih.gov/2005/menopauseabstracts.pdf
   Google Scholar